A detailed history of Moneta Group Investment Advisors LLC transactions in Cybin Inc. stock. As of the latest transaction made, Moneta Group Investment Advisors LLC holds 108,481 shares of CYBN stock, worth $961,141. This represents 0.0% of its overall portfolio holdings.

Number of Shares
108,481
Previous 113,900 4.76%
Holding current value
$961,141
Previous $46,000 36.96%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$0.26 - $0.46 $1,408 - $2,492
-5,419 Reduced 4.76%
108,481 $29,000
Q1 2024

Aug 13, 2024

BUY
$0.3 - $0.46 $19,546 - $29,970
65,154 Added 133.66%
113,900 $46,000
Q4 2023

Feb 15, 2024

BUY
$0.38 - $0.65 $87 - $148
229 Added 0.47%
48,746 $19,000
Q3 2023

Nov 15, 2023

BUY
$0.29 - $0.63 $3,386 - $7,357
11,679 Added 31.7%
48,517 $25,000
Q2 2023

Aug 15, 2023

SELL
$0.23 - $0.39 $2,927 - $4,963
-12,728 Reduced 25.68%
36,838 $13,000
Q1 2023

May 15, 2023

BUY
$0.3 - $0.56 $3,333 - $6,221
11,110 Added 28.89%
49,566 $18,000
Q4 2022

Feb 16, 2023

SELL
$0.26 - $0.64 $7,266 - $17,887
-27,949 Reduced 42.09%
38,456 $11,000
Q4 2022

Feb 16, 2023

SELL
$0.26 - $0.64 $17.2 Million - $42.5 Million
-66,338,846 Reduced 99.9%
66,405 $19,000
Q4 2022

Feb 15, 2023

BUY
$0.26 - $0.64 $17.3 Million - $42.5 Million
66,355,664 Added 133816.66%
66,405,251 $19.7 Million
Q3 2022

Nov 14, 2022

SELL
$0.48 - $1.11 $1,531 - $3,542
-3,191 Reduced 6.05%
49,587 $24,000
Q2 2022

Aug 15, 2022

BUY
$0.41 - $0.88 $21,638 - $46,444
52,778 New
52,778 $38,000

Others Institutions Holding CYBN

About CYBIN INC.


  • Ticker CYBN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 166,120,000
  • Market Cap $1.47B
  • Description
  • Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to t...
More about CYBN
Track This Portfolio

Track Moneta Group Investment Advisors LLC Portfolio

Follow Moneta Group Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moneta Group Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Moneta Group Investment Advisors LLC with notifications on news.